EX-23.1 5 0005.txt CONSENT OF KPMG LLP EXHIBIT 23.1 Independent Auditor's Consent The Board of Directors Nastech Pharmaceutical Company Inc.: We consent to the use of our report dated February 2, 2001, except for Note 16 which is dated as of March 22, 2001, incorporated herein by reference and to the reference to our firm under the heading "Experts" in the prospectus. KPMG LLP Melville, New York June 12, 2001